Login
Register
Back to News
Silence Therapeutics shares are trading lower after the company reported worse-than-expected Q4 sales results.
Benzinga Newsdesk
www.benzinga.com
Negative 97.2%
Neg 97.2%
Neu 0%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment